Related references
Note: Only part of the references are listed.Risk factors for Covid-19 severity and fatality: a structured literature review
Dominik Wolff et al.
INFECTION (2021)
Risk factors for severe and critically ill COVID-19 patients: A review
Ya-dong Gao et al.
ALLERGY (2021)
Apoptosis-induced T-cell lymphopenia is related to COVID-19 severity
Ahmet Cizmecioglu et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity
Egle Kvedaraite et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn
Cinzia Signorini et al.
LIFE-BASEL (2021)
Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity
Sara Falck-Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Biomarkers in COVID-19: An Up-To-Date Review
Madhusudan Samprathi et al.
FRONTIERS IN PEDIATRICS (2021)
Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma
Francoise Gondois-Rey et al.
CANCERS (2021)
Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in Japan
Tomohiro Takano et al.
INTERNATIONAL IMMUNOLOGY (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Ahmet Kursat Azkur et al.
ALLERGY (2020)
Hematological findings and complications of COVID-19
Evangelos Terpos et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
Aymeric Silvin et al.
CELL (2020)
Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)
Chiara Agrati et al.
CELL DEATH AND DIFFERENTIATION (2020)
Risk factors for severe COVID-19 in middle-aged patients without comorbidities: a multicentre retrospective study
Peng Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome
Alessandra Sacchi et al.
CELL DEATH & DISEASE (2020)
Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies
Maria Silvia Cona et al.
CANCERS (2019)
C-Reactive Protein Promotes the Expansion of Myeloid Derived Cells With Suppressor Functions
Rachel V. Jimenez et al.
FRONTIERS IN IMMUNOLOGY (2019)
Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets
Stephan Lang et al.
CLINICAL CANCER RESEARCH (2018)
Myeloid-derived suppressor cells coming of age
Filippo Veglia et al.
NATURE IMMUNOLOGY (2018)
The Role of Myeloid-Derived Suppressor Cells in Viral Infection
Megan A. O'Connor et al.
VIRAL IMMUNOLOGY (2017)
Monocytic myeloid-derived suppressor cells regulate T-cell responses against vaccinia virus
Carl Fortin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Human Myeloid-derived Suppressor Cells are Associated With Chronic Immune Suppression After Severe Sepsis/Septic Shock
Brittany Mathias et al.
ANNALS OF SURGERY (2017)
Assessment of Clinical Criteria for Sepsis For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Christopher W. Seymour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Polarization of Monocytic Myeloid-Derived Suppressor Cells by Hepatitis B Surface Antigen Is Mediated via ERK/IL-6/STAT3 Signaling Feedback and Restrains the Activation of T Cells in Chronic Hepatitis B Virus Infection
Zhong Fang et al.
JOURNAL OF IMMUNOLOGY (2015)
A Method for Identification and Analysis of Non-Overlapping Myeloid Immunophenotypes in Humans
Michael P. Gustafson et al.
PLOS ONE (2015)
HIV Type 1 gp120-Induced Expansion of Myeloid Derived Suppressor Cells Is Dependent on Interleukin 6 and Suppresses Immunity
Ankita Garg et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?
Celeste Goh et al.
IMMUNOLOGICAL REVIEWS (2013)
Clinical Significance and Functional Studies of Myeloid-Derived Suppressor Cells in Chronic Hepatitis C Patients
Weiping Cai et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells
T. Vollbrecht et al.
RETROVIROLOGY (2012)
STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2005)
Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species
S Kusmartsev et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)